Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 190   

Articles published

VRX 15.46 +0.02 (0.16%)
price chart
Canadian and U.S. pharma stocks tumble as 'vicious' Trump vows to 'bring down ...
Over the past 18 months, companies including EpiPen allergy shot maker Mylan and Valeant Pharmaceuticals International Inc.
Valeant Stock: Is Trump About to Kill Pharmaceutical Stocks?  Profit Confidential
Valeant Pharmaceuticals Intl Inc. Will Continue to Be a Loser in 2017
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) had a disaster of a year, as the stock continued its decline into the abyss.
Analysts View Unchanged As Valeant Pharmaceuticals Announces Positive IDP ...  TCC
Valeant Pharmaceuticals International Inc downgraded again
Valeant Pharmaceuticals International Inc. was once again downgraded to underperform from neutral by Irina Koffler at Mizuho Securities, who thinks patience is likely to wane for investors in the troubled pharma giant.
Valeant Pharmaceuticals Intl Inc: More Bad News for VRX Stock  Profit Confidential
Top-Ranked Analyst Says Sell Valeant Pharmaceuticals Intl Inc (VRX), Buy ...  Smarter Analyst
Valeant Pharmaceuticals International needs to do a lot more than just cry ...
Valeant is the asset seller that cried “wolf.” Every couple of weeks, it seems, a new Valeant Pharmaceuticals International Inc. asset is reported to be up for sale as the company seeks to pay down some of its US$30 billion in debt. Earlier in the ...
What's Valeant Pharmaceuticals Intl Inc Upside After Today's Huge ...  Frisco Fastball
Two Eye-Catching Stocks: Williams Companies, Inc. (NYSE:WMB), Valeant ...  FactsReporter
Valeant Pharmaceuticals Intl Inc.: Is This Stock Worth a Contrarian Shot for 2017?
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is one of Canada's most hated stocks, and investors with an eye for potential turnaround stories are wondering if it might be time to start nibbling on the beleaguered drug maker.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) To Retain Salix After ...  Market Exclusive
Valeant Announces The Initiation Of A Primary Care Sales Force For Xifaxan ...  PR Newswire (press release)
The Bears and the Bulls: Analysts Divided on Valeant Pharmaceuticals Intl Inc ...
Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and Biogen Inc (NASDAQ:BIIB) have recently given biotech investors a lot of food for thought with new clinical updates, from Valeant's positive psoriasis drug data read-out to Biogen's key abstracts shared ...
Valeant Pharmaceuticals Intl Inc. Drops After Q3 Results Disappoint
Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continued the downward slide that started a year ago; the stock plummeted another 20% on weaker than expected results.
FY2016 EPS Estimates for Valeant Pharmaceuticals International Inc ...  BBNS
Wall Street Allocates Price Target Of $31.384 To Valeant Pharmaceuticals ...  Transcript Daily
Should You Buy Valeant Pharmaceuticals Intl Inc. After its 22% Plunge?
Valeant Pharmaceuticals International Inc. (TSX:VRX)(NYSE:VRX) took another plunge, as the latest financial results were a disaster.
Valeant Pharmaceuticals Intl Inc: VRX Stock Rises Again  Profit Confidential
Biotech Talk: Valeant Pharmaceuticals Intl Inc (VRX) and Endo International ...  Smarter Analyst
Valeant Pharmaceuticals Intl Inc.: Has This Stock Finally Hit Bottom?
Investors have been burned time and again over the past year trying to call a bottom in Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), which was briefly Canada's most valuable company in 2015.
The Biotech Corner: Valeant Pharmaceuticals Intl Inc (VRX), Regeneron ...  Smarter Analyst
Two Are Charged In Fraud And Kickback Scheme Against Valeant Pharmaceuticals  Forbes
Why Bill Ackman Should Give Up on Valeant Pharmaceuticals Intl Inc.
Bill Ackman has stood by his investment in Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), despite losing over 90% of his original investment.
BMO Capital Cuts Price Target On Valeant Pharmaceuticals Intl Inc (NYSE:VRX)  TCC
Most Active Weekly Options: Valeant Pharmaceuticals Intl Inc and Tesla ...  Schaeffers Research (blog)